Dimitra Papadopoulou

A wonderful collaboration with the medicinal chemistry lab of Alexios Matralis and valued colleagues! First small molecule leads targeting #fibroblast activation driving chronic #inflammatorydisease and #fibrosis.

Yes! It's public! Our lab's new work providing the first evidence of spatial spreading of intestinal inflammation via distinct fibroblast subsets. Amazing work .. all because of amazing Lida et al! @BSRC_Fleming @CrohnsColitisFn @ERC_Research biorxiv.org/content/10.110…

Proud and extremely happy to see our recent work published  today @NAR_Open! Congratulations to all the (past and present) members of the #MFlab @BSRC_Fleming that contributed! academic.oup.com/nar/advance-ar…

An antipsychotic drug reduces arthritis in a fibroblast dependent model! Take a look on our work from @KolliasLab at @BSRC_Fleming published now in @JCI_insight. Thanks to our collaborators @Biomedcode @JesperOlsenLab

Happy that our work at @KolliasLab in @BSRC_Fleming is now available as a preprint! @biorxivpreprint #arthritis #fibroblasts #DrugRepurposing

The @KolliasLab @BSRC_Fleming is seeking motivated #postdocs to join a newly awarded #ERCAdG on “Contextual specification of #fibroblast driven causalities in #IBD and #fibrosis” @ERC_Research Info: bit.ly/3N8KIF3

Kollias and colleagues examine FRC development during lymphoid organogenesis in gut PP: two separate mesenchymal cell lineages converge and form mosaic microenvironments that support immune cell activation and maintain intestinal homeostasis rdcu.be/cgNVz